2024年12月16日 · Last year, we documented nine biotechs we thought you should watch in 2024. Now, as the year has flown by and the end of 2024 is approaching, biotech companies will be setting out their plans for next year as they continue to work towards bringing their innovative therapies through the clinic and to the market in an attempt to bring new and groundbreaking medicines to patients suffering from ...

January 2025:. 22-23 January 2025: Paris, France – Pharmapack 28-30 January 2025: Frankfurt, Germany – mRNA-based Therapeutics Summit 29-30 January 2025: London, UK – Festival of Genomics and Biodata; February 2025: 4 February 2025: Zurich, Switzerland – Zurich Life Science Day 2025; 6-8 February 2025: Strasbourg, France – 7th European CAR T-cell Meeting

Discover the latest in biotech funding on our dedicated page. We meticulously curate and categorize significant fundraising events to keep you informed about the cutting-edge trends and investments driving the industry forward.

January 2024: AbbVie and Umoja Biopharma, both based in the United States, are partnering to develop novel in-situ CAR-T cell therapies. Umoja is eligible to receive up to $1.44 billion for option exercise fees, development, and regulatory milestones.

2024年10月9日 · FDA approves two new COPD treatments in 2024 Verona Pharma’s Ohtuvayre. In June 2024, the FDA approved the first inhaled product with a novel mechanism of action available for the maintenance treatment of COPD in more than 20 years. The product, called Ohtuvayre (ensifentrine), was developed by Verona Pharma – a London-based company established 19 years ago to unlock the potential of ...

2024年6月14日 · For instance, a therapeutics company “goes after a very targeted local monopoly or local oligopoly,” explained Van den Berghe. For these companies, it doesn’t necessarily matter if the team changes along the research and development (R&D) stage — at least not to the extent that it affects non-therapeutic biotechs.

2024年8月29日 · Aelix Therapeutics . Aelix Therapeutics is a clinical-stage biotech company based in Barcelona, in the northeast of Spain. It is a spin-off of HIVACAT – a Catalan program for the development of therapeutic vaccines and prevention against human immunodeficiency virus (HIV) – and is focused on developing a new therapeutic vaccine for HIV that can be included in cure and eradication strategies.

4 天之前 · Labiotech.eu covers the global biotech industry, read by 150,000+ monthly visitors. Hope you'll enjoy our Biotech News!

2023年9月19日 · Known throughout history for being home to the iconic scene of Hollywood, in recent years Los Angeles has also become a thriving biotech hub, after years of playing second fiddle in the U.S. to the likes of South San Francisco and Boston.In this article, we take a look at five of the best Los Angeles biotech companies around today.

2024年1月5日 · In November 2023, Cradle raised $24 million in series A financing led by Index Ventures with participation from Kindred Capital. This funding round took the total raised by the AI drug discovery company to date to $33 million. Exscientia . Considered a pioneer in the field of AI within the biopharma industry, Exscientia is an AI-driven precision medicine company committed to discovering ...